The market's expectation of limited future growth for Changchun High-Tech Industries (Group) results in its low P/E ratio. Investors' reduced willingness to pay for the stock forms a barrier for the share price.
生長激素概念股集體下挫,安科生物跌超15%,長春高新跌停,此前新華社點名“增高針”亂象。 Shares of Anhui Anke Biotechnology dives 15% and Changchun High-Tech Industries hits the limit down after the criticism of XHNews on their medical beauty technologies. $安科生物(300009.SZ)$ $長春高新(000661.SZ)$
長春高新股票討論區
Shares of Anhui Anke Biotechnology dives 15% and Changchun High-Tech Industries hits the limit down after the criticism of XHNews on their medical beauty technologies.
$安科生物(300009.SZ)$
$長春高新(000661.SZ)$
暫無評論